Jun Thorsteinsdottir1, Christian Vollmar2, Jörg-Christian Tonn1, Friedrich-Wilhelm Kreth1, Soheyl Noachtar2, Aurelia Peraud3,4. 1. Department of Neurosurgery, University Hospital of Munich, Ludwig-Maximilians-University, Marchioninistr. 15, 81377, Munich, Germany. 2. Department of Neurology, University Hospital of Munich, Ludwig-Maximilians-University, Marchioninistr. 15, 81377, Munich, Germany. 3. Department of Neurosurgery, University Hospital of Munich, Ludwig-Maximilians-University, Marchioninistr. 15, 81377, Munich, Germany. Aurelia.Peraud@uniklinik-ulm.de. 4. Department of Neurosurgery, University Hospital of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. Aurelia.Peraud@uniklinik-ulm.de.
Abstract
BACKGROUND: Refined localization of the epileptogenic zone (EZ) in patients with pharmacoresistant focal epilepsy proceeding to resective surgery might improve postoperative outcome. We here report seizure outcome after stereo EEG (sEEG) evaluation with individually planned stereotactically implanted depth electrodes and subsequent tailored resection. METHODS: A cohort of consecutive patients with pharmacoresistant focal epilepsy, evaluated with a non-invasive evaluation protocol and invasive monitoring with personalized, stereotactically implanted depth electrodes for sEEG was analyzed. Co-registration of post-implantation CT scan to presurgical MRI data was used for 3D reconstructions of the patients' brain surface and mapping of neurophysiology data. Individual multimodal 3D maps of the EZ were used to guide subsequent tailored resections. The outcome was rated according to the Engel classification. RESULTS: Out of 914 patients who underwent non-invasive presurgical evaluation, 85 underwent sEEG, and 70 were included in the outcome analysis. Median follow-up was 31.5 months. Seizure-free outcome (Engel class I A-C, ILAE class 1-2) was achieved in 83% of the study cohort. Patients exhibiting lesional and non-lesional (n = 42, 86% vs. n = 28, 79%), temporal and extratemporal (n = 45, 80% vs. n = 25, 84%), and right- and left-hemispheric epilepsy (n = 44, 82% vs. n = 26, 85%) did similarly well. This remains also true for those with an EZ adjacent to or distant from eloquent cortex (n = 21, 86% vs. n = 49, 82%). Surgical outcome was independent of resected tissue volume. CONCLUSION: Favourable post-surgical outcome can be achieved in patients with resistant focal epilepsy, using individualized sEEG evaluation and tailored navigated resection, even in patients with non-lesional or extratemporal focal epilepsy.
BACKGROUND: Refined localization of the epileptogenic zone (EZ) in patients with pharmacoresistant focal epilepsy proceeding to resective surgery might improve postoperative outcome. We here report seizure outcome after stereo EEG (sEEG) evaluation with individually planned stereotactically implanted depth electrodes and subsequent tailored resection. METHODS: A cohort of consecutive patients with pharmacoresistant focal epilepsy, evaluated with a non-invasive evaluation protocol and invasive monitoring with personalized, stereotactically implanted depth electrodes for sEEG was analyzed. Co-registration of post-implantation CT scan to presurgical MRI data was used for 3D reconstructions of the patients' brain surface and mapping of neurophysiology data. Individual multimodal 3D maps of the EZ were used to guide subsequent tailored resections. The outcome was rated according to the Engel classification. RESULTS: Out of 914 patients who underwent non-invasive presurgical evaluation, 85 underwent sEEG, and 70 were included in the outcome analysis. Median follow-up was 31.5 months. Seizure-free outcome (Engel class I A-C, ILAE class 1-2) was achieved in 83% of the study cohort. Patients exhibiting lesional and non-lesional (n = 42, 86% vs. n = 28, 79%), temporal and extratemporal (n = 45, 80% vs. n = 25, 84%), and right- and left-hemispheric epilepsy (n = 44, 82% vs. n = 26, 85%) did similarly well. This remains also true for those with an EZ adjacent to or distant from eloquent cortex (n = 21, 86% vs. n = 49, 82%). Surgical outcome was independent of resected tissue volume. CONCLUSION: Favourable post-surgical outcome can be achieved in patients with resistant focal epilepsy, using individualized sEEG evaluation and tailored navigated resection, even in patients with non-lesional or extratemporal focal epilepsy.
Authors: T J O'Brien; E L So; B P Mullan; G D Cascino; M F Hauser; B H Brinkmann; F W Sharbrough; F B Meyer Journal: Neurology Date: 2000-12-12 Impact factor: 9.910
Authors: H G Wieser; W T Blume; D Fish; E Goldensohn; A Hufnagel; D King; M R Sperling; H Lüders; T A Pedley Journal: Epilepsia Date: 2001-02 Impact factor: 5.864
Authors: Horst Urbach; Devin Binder; Marec von Lehe; Martin Podlogar; Christian G Bien; Albert Becker; Johannes Schramm; Thomas Kral; Hans Clusmann Journal: Seizure Date: 2007-06-11 Impact factor: 3.184
Authors: Jung Ju Lee; Sang Kun Lee; Seo-Young Lee; Kyung-Il Park; Dong Wook Kim; Dong Soo Lee; Chun Kee Chung; Hyeon Woo Nam Journal: Seizure Date: 2008-03-10 Impact factor: 3.184
Authors: Barbara Ladisich; Lukas Machegger; Alexander Romagna; Herbert Krainz; Jürgen Steinbacher; Markus Leitinger; Gudrun Kalss; Niklas Thon; Eugen Trinka; Peter A Winkler; Christoph Schwartz Journal: Acta Neurochir (Wien) Date: 2021-02-13 Impact factor: 2.216